Sunshine Guojian Pharmaceutical Co., Ltd.

Sunshine Guojian Pharmaceutical Co., Ltd. is a biopharmaceutical company specializing in the research, development, and manufacture of innovative therapeutic drugs, with a strong emphasis on monoclonal antibodies. As a key player in the biotechnology sector, Sunshine Guojian integrates advanced technology platforms and a thorough understanding of complex biological processes to deliver targeted treatment solutions. The company's product portfolio addresses critical therapeutic areas such as oncology, autoimmune disorders, and infectious diseases, contributing significantly to global medical advancements in these fields. With an operational base in China, Sunshine Guojian plays an essential role in the local healthcare market while simultaneously expanding its impact on an international scale. The company emphasizes the importance of innovation and technical expertise, collaborating with researchers and healthcare providers to enhance the efficacy and accessibility of biotherapeutic products. Sunshine Guojian Pharmaceutical Co., Ltd. advances the pharmaceutical industry by establishing pipelines of next-generation therapies aimed at improving patient outcomes and quality of life.